Paper20005905
RNA immunization can protect mice against foot-and-mouth disease virus.
Pulido MR and 3 others. Antiviral Res, 2010. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. RNA immunization can protect mice against foot-and-mouth disease virus. Papers, record 20005905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20005905
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Foot-and-Mouth Disease | Major topic |
| Foot-and-Mouth Disease Virus | Major topic |
| Immunization | Major topic |
| RNA, Viral | Major topic |
| Viral Vaccines | Major topic |
| Animals | |
| Antibodies, Neutralizing | |
| Antibodies, Viral | |
| Mice | |
| Swine |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41472004 | Advances in Infectious Bursal Disease Virus Vaccines-A Review. | Microorganisms | 2025 | https://conductscience.org/library/papers/41472004 | PubMed |
| 40813770 | A self-amplifying mRNA vaccine expressing PRV gD induces robust immunity against virulent mutants. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40813770 | PubMed |
| 40695813 | Development of an mRNA vaccine encoding IHNV glycoprotein protects rainbow trout (Oncorhynchus mykiss) from infection. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/40695813 | PubMed |
| 40266104 | Porcine Reproductive and Respiratory Syndrome Virus: Challenges and Advances in Vaccine Development. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40266104 | PubMed |
| 40214462 | Role of T Follicular Helper Cells in Viral Infections and Vaccine Design. | Cells | 2025 | https://conductscience.org/library/papers/40214462 | PubMed |
| 37885619 | The combination of vaccines and adjuvants to prevent the occurrence of high incidence of infectious diseases in bovine. | Front Vet Sci | 2023 | https://conductscience.org/library/papers/37885619 | PubMed |
| 36992505 | B and T Cell Epitopes of the Incursionary Foot-and-Mouth Disease Virus Serotype SAT2 for Vaccine Development. | Viruses | 2023 | https://conductscience.org/library/papers/36992505 | PubMed |
| 35215994 | mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases. | Viruses | 2022 | https://conductscience.org/library/papers/35215994 | PubMed |
| 32653463 | Vaccines for COVID-19: The current state of play. | Paediatr Respir Rev | 2020 | https://conductscience.org/library/papers/32653463 | PubMed |
| 30972078 | Advances in mRNA Vaccines for Infectious Diseases. | Front Immunol | 2019 | https://conductscience.org/library/papers/30972078 | PubMed |
| 23011030 | Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. | Mol Ther | 2013 | https://conductscience.org/library/papers/23011030 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20005905
GET https://conductscience.org/api/papers/v1/20005905/authors